NUZ 0.00% 19.0¢ neurizon therapeutics limited

Ann: MND Trial Successfully Completes Second Patient Cohort, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,421 Posts.
    lightbulb Created with Sketch. 1010
    Don't get me wrong, it's a great announcement. I'm just a bit confused as to why in the first part (the bullet points) they say that "One" patient has shown stable disease. But then further on it says that 5 patients have been dosed for 6 months with no adverse effects and have shown "stable" disease giving the impression that it is all of them, not just one are stable. This is a big difference so I wonder which is correct? Or has one patient undergone some sort of test to confirm stable disease whereas the others haven't yet, but never the less "appear" stable?
    I guess we'll find out for sure in late May when the results come back.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $93.42M
Open High Low Value Volume
19.0¢ 19.3¢ 19.0¢ $36.02K 189.6K

Buyers (Bids)

No. Vol. Price($)
1 8997 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 290222 5
View Market Depth
Last trade - 15.58pm 06/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.